Altered gene expression levels of genes related to muscle function in adults with cerebral palsy
J Pingel, J Vandenrijt, ML Kampmann, JD Andersen - Tissue and Cell, 2022 - Elsevier
Cerebral palsy (CP) is the most common cause of movement disorders in children. Next
generation sequencing (NGS) studies have previously shown that expression levels are …
generation sequencing (NGS) studies have previously shown that expression levels are …
[HTML][HTML] Effect of extracorporeal shock wave therapy on spastic equinus foot in children with unilateral cerebral palsy
HA Emara, AH Al-Johani, OA Khaled… - Journal of Taibah …, 2022 - Elsevier
Objectives This study aims to investigate the effects of radial extracorporeal shock wave
therapy on selective motor control, spasticity, gross motor function, and balance in children …
therapy on selective motor control, spasticity, gross motor function, and balance in children …
Quantitative assessment of change in upper extremity muscle stiffness following fluid injection using shear wave elastography
OK Nwawka, N Gutierrez, B Lin, LM Ko, TT Miller - Skeletal Radiology, 2021 - Springer
Objective To quantitatively assess changes in muscle stiffness following intramuscular
saline injection using shear wave elastography (SWE). Materials and methods Thirty …
saline injection using shear wave elastography (SWE). Materials and methods Thirty …
Effects of stochastic resonance stimulation on manual function in children with hemiplegic cerebral palsy: A pilot clinical trial
J Lynn, A Wolf, T Bridges, Z Pottanat, S Spivey, O Rolin - PM&R, 2023 - Wiley Online Library
Objective To investigate the effect of stochastic resonance stimulation (SRS) on manual
abilities in children with hemiplegic cerebral palsy. Design This pilot study is a randomized …
abilities in children with hemiplegic cerebral palsy. Design This pilot study is a randomized …
Perceived Barriers, Enablers, and Modifications to Tests Assessing Pediatric Lower Limb Neurological Impairment: An International Delphi Survey
Objectives Accurate, clinically meaningful outcome measures that are responsive to change
are essential for selecting interventions and assessing their effects. Little guidance exists on …
are essential for selecting interventions and assessing their effects. Little guidance exists on …
Adverse events after different forms of botulinum neurotoxin A injections in children with cerebral palsy: An 8‐year retrospective study
J Li, L He, H Tang, T Peng, Y Long… - … Medicine & Child …, 2023 - Wiley Online Library
Aim To compare the risks of adverse events 3 months after Onabotulinumtoxin‐A and
Lanbotulinumtoxin‐A injections in children with cerebral palsy (CP) and to identify risk …
Lanbotulinumtoxin‐A injections in children with cerebral palsy (CP) and to identify risk …
Clinical presentation of spasticity and passive range of motion deviations in dyskinetic cerebral palsy in relation to dystonia, choreoathetosis, and functional …
S Bekteshi, I Vanmechelen, M Konings… - Developmental …, 2021 - Taylor & Francis
Objectives: To map the presence, severity, and distribution of spasticity and passive range of
motion (pROM) deviations in dyskinetic cerebral palsy (DCP), and to explore their relation …
motion (pROM) deviations in dyskinetic cerebral palsy (DCP), and to explore their relation …
Physical characteristics and upper‐limb treatment with botulinum neurotoxin A in children with cerebral palsy: A population‐based study
J Hedberg‐Graff, F Granström… - … Medicine & Child …, 2023 - Wiley Online Library
Aim To describe the use of upper‐limb botulinum neurotoxin A (BoNT‐A) treatment in a
population‐based sample of children with cerebral palsy (CP), by investigating whether …
population‐based sample of children with cerebral palsy (CP), by investigating whether …
[PDF][PDF] Cerebral Palsy: An Overview.
K Duman - Hamidiye Medical Journal, 2022 - cms.hamidiyemedj.com
ÖZ Cerebral palsy (CP), the most common cause of disability in childhood, was first
described in 1861 by the English orthopedist William Little. CP, which has been expressed …
described in 1861 by the English orthopedist William Little. CP, which has been expressed …
Lanbotulinumtoxin‐A: Safe for children with cerebral palsy but is it effective?
T Hastings‐Ison, K Graham - Developmental Medicine and Child …, 2023 - ncbi.nlm.nih.gov
1. Fasano VA, Broggi G, Barolat-Romana G, Sguazzi A. Surgical treatment of spasticity in
cerebral palsy. Childs Brain 1978; 4: 289–305. 2. Park TS, Gaffney PE, Kaufman BA …
cerebral palsy. Childs Brain 1978; 4: 289–305. 2. Park TS, Gaffney PE, Kaufman BA …